Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,641 across all filing types
Latest filing 2024-11-12 Director's Dealing
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
Form 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 2 pages 12.2KB
Director's Dealing Classification · 100% confidence The document is a Form 4 filed with the U.S. Securities and Exchange Commission, which is a Statement of Changes in Beneficial Ownership pursuant to Section 16(a) of the Securities Exchange Act of 1934. It details insider transactions by Brett Sandercock, the Chief Financial Officer of ResMed Inc., including dates, amounts, and nature of securities acquired or disposed of. This type of filing is specifically related to insider share transactions by company directors or executives. Therefore, it fits the category of Director's Dealing (DIRS). The document is not a financial report, earnings release, or any other type of corporate report but a regulatory filing of insider transactions.
2024-11-12 English
Form 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 2 pages 13.2KB
Director's Dealing Classification · 100% confidence The document is a Form 4 filed with the U.S. Securities and Exchange Commission, which is a Statement of Changes in Beneficial Ownership. It details transactions by insiders such as officers or directors involving the company's securities. The presence of transaction dates, security titles, and ownership details confirms this is a report of insider share transactions. This matches the definition of Director's Dealing filings, which report personal share transactions by company directors and executives (insider trades). The document is not an annual report, earnings release, or any other type of financial or regulatory report but specifically a Form 4 insider transaction filing.
2024-11-12 English
Form 4 Statement of changes in beneficial ownership of secur 2 pages 14.5KB
Director's Dealing Classification · 100% confidence The document is a Form 4 filed with the U.S. Securities and Exchange Commission (SEC), which is a statement of changes in beneficial ownership of securities by insiders such as officers or directors. It details transactions in the company's stock by Michael J. Farrell, the CEO of ResMed Inc., including acquisitions and dispositions of common stock and stock options. The form is filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, which requires insiders to report their transactions. This type of filing is specifically related to insider trading disclosures and personal share transactions by company directors and executives. Therefore, the document fits the category of Director's Dealing (DIRS). The document length and content confirm it is not a brief announcement or a certification but a detailed insider transaction report.
2024-11-12 English
Form 4 Statement of changes in beneficial ownership of secur 2 pages 13.2KB
Director's Dealing Classification · 100% confidence The document is a Form 4 filed with the SEC, which is a Statement of Changes in Beneficial Ownership. It reports transactions in the company's securities by insiders such as directors and officers. The presence of detailed tables showing securities acquired or disposed of, transaction dates, and ownership forms confirms this is a report of insider share transactions. This matches the definition of Director's Dealing filings, which report personal share transactions by company directors and executives (insider trades). The document is not an annual report, earnings release, or any other type of financial or regulatory filing. Therefore, the correct classification is DIRS.
2024-11-12 English
From 4 Statement of changes in beneficial ownership of secur 2 pages 12.1KB
Director's Dealing Classification · 100% confidence The document is a Form 4 filed with the United States Securities and Exchange Commission (SEC). It is titled 'STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP' and is filed pursuant to Section 16(a) of the Securities Exchange Act of 1934. The form details transactions by a company insider (a director) involving the company's securities, including dates, amounts, and nature of ownership. This type of filing is specifically used to report insider transactions and changes in ownership by directors and officers. It is not an earnings release, annual report, or any other type of financial or management report. Therefore, it fits the category of Director's Dealing filings.
2024-11-12 English
Form 4 Statement of changes in beneficial ownership of secur 2 pages 12.1KB
Director's Dealing Classification · 100% confidence The document is a Form 4 filed with the U.S. Securities and Exchange Commission, which is a statement of changes in beneficial ownership of company securities by insiders such as directors or officers. It details transactions in the company's stock by a reporting person, including dates, amounts, and nature of ownership. This type of filing is specifically related to insider trading disclosures and personal share transactions by company directors and executives. It is not a financial report, earnings release, or any other type of corporate report. Therefore, the correct classification is Director's Dealing (DIRS). The document length and content confirm it is a full Form 4 filing, not just an announcement or certification.
2024-11-12 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.